Practice Profile: Corporate partner Gareth Clark focuses on international private equity and M&A deals, such as leveraged buyouts, carve-out transactions, growth capital investments, going-private transactions and divestitures. Over the past year, Mr. Clark has guided Cerberus Capital Management through the sale of California biotech PaxVax to Emergent Biosolutions, a complex cross-border deal touching on multiple jurisdictions, and coordinated the global team shepherding One Equity Partners and its portfolio company, PeroxyChem, through the pending $625 million sale of PeroxyChem to Germany’s Evonik Industries. Also over the past year, he played a key role in representing NASDAQ-listed Centric Brands (f/k/a Differential Brands Group) in its acquisition of a significant part of the North American licensing business of Hong Kong-listed Global Brands Group, a US$1.2 billion carve-out deal that spanned three continents and multiple practice areas.

Leadership, Pro Bono and Civic Work: Mr. Clark sits on Dechert’s hiring committee and co-chairs its LGBTQ affinity group, which recently launched a mentoring program for LGBTQ law students at various New York law schools, including Columbia, Fordham and NYU. He also serves as Co-Diversity Liaison Partner for the firm’s corporate department, which helps him ensure that diverse attorneys are considered for leadership positions and included on client pitches and key deals.